Related Experiment Video
Updated: May 24, 2026
09:24
Systemic Injection of Neural Stem/Progenitor Cells in Mice with Chronic EAE
Published on: April 15, 2014
Stem cell therapy for multiple sclerosis: preclinical evidence beyond all doubt?
Kristien Reekmans1, Jelle Praet, Nathalie De Vocht
1Laboratory of Experimental Hematology, Vaccine & Infectious Disease Institute (Vaxinfectio), University of Antwerp, Universiteitsplein 1, 2610 Antwerp, Belgium.
Regenerative Medicine
|March 9, 2012
Summary
Stem cell therapy shows promise for multiple sclerosis (MS) by restoring neural function. Further research is needed to optimize delivery and understand mechanisms for successful clinical translation in MS patients.
Area of Science:
- Neuroscience
- Immunology
- Regenerative Medicine
Background:
- Stem cell transplantation is a promising approach for neurodegenerative disorders like multiple sclerosis (MS).
- Significant questions persist regarding the efficacy and mechanisms of action for stem cell therapies in MS.
- Experimental autoimmune encephalomyelitis (EAE) serves as a key preclinical model for studying MS.
Purpose of the Study:
- To discuss optimal administration routes and timing for stem cell therapies in EAE models.
- To review proposed mechanisms underlying the therapeutic benefits of stem cell transplantation in EAE.
- To identify challenges hindering the translation of stem cell therapy from EAE models to human MS treatment.
Main Methods:
- Literature review of stem cell therapy studies in rodent EAE models.
- Analysis of proposed mechanisms of action for stem cell transplantation.
- Evaluation of current and historical stem cell-based approaches for EAE/MS.
Main Results:
- Conceptual advancements in stem cell therapy development for EAE/MS have been identified.
- Key challenges in translating EAE stem cell therapy to human MS treatment are highlighted.
- Understanding optimal timing and routes for stem cell administration in EAE is crucial.
Conclusions:
- Stem cell transplantation offers potential for neural function restoration in MS.
- Further research is essential to clarify mechanisms and optimize therapeutic strategies for MS.
- Overcoming identified challenges is critical for safe and effective clinical translation of stem cell therapy for MS.
Related Concept Videos
01:19Mesenchymal Stem Cells
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their access...
01:22iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
01:06Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Somatic cells are...
01:13Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
01:19Multipotency of Hematopoietic Stem Cells
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
01:21Stem Cell Therapy for Tissue Regeneration
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...